GH Research (GHRS) Short Interest Ratio & Short Volume $11.79 -0.66 (-5.30%) Closing price 04:00 PM EasternExtended Trading$11.80 +0.01 (+0.04%) As of 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GH Research Short Interest DataGH Research (GHRS) has a short interest of 2.82 million shares, representing 6.97% of the float (the number of shares available for trading by the public). This marks a -2.08% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.8, indicating that it would take 10.8 days of the average trading volume of 179,128 shares to cover all short positions.Current Short Interest2,820,000 sharesPrevious Short Interest2,880,000 sharesChange Vs. Previous Month-2.08%Dollar Volume Sold Short$26.90 millionShort Interest Ratio10.8 Days to CoverLast Record DateApril 30, 2025Outstanding Shares52,028,000 sharesFloat Size40,440,000 sharesShort Percent of Float6.97%Today's Trading Volume175,675 sharesAverage Trading Volume179,128 sharesToday's Volume Vs. Average98% Short Selling GH Research? Sign up to receive the latest short interest report for GH Research and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGHRS Short Interest Over TimeGHRS Days to Cover Over TimeGHRS Percentage of Float Shorted Over Time GH Research Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20252,820,000 shares $26.90 million -2.1%7.0%10.8 $9.54 4/15/20252,880,000 shares $25.89 million +4.0%7.1%5.7 $8.99 3/31/20252,770,000 shares $30.55 million -3.8%6.9%5.6 $11.03 3/15/20252,880,000 shares $31.68 million +0.7%7.1%6.2 $11.00 2/28/20252,860,000 shares $28.97 million -0.4%7.1%6.5 $10.13 2/15/20252,870,000 shares $41.07 million +21.1%7.9%7.1 $14.31 1/31/20252,370,000 shares $25.12 million -1.7%7.8%6.4 $10.60 1/15/20252,410,000 shares $20.39 million +5.7%7.9%33.1 $8.46 12/31/20242,280,000 shares $15.96 million +11.8%7.5%31.3 $7.00 12/15/20242,040,000 shares $15.79 million +3.0%6.7%31.4 $7.74 Get the Latest News and Ratings for GHRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GH Research and its competitors with MarketBeat's FREE daily newsletter. 11/30/20241,980,000 shares $17.68 million No Change6.5%32.9 $8.93 11/15/20241,980,000 shares $18.00 million +3.7%6.5%34.5 $9.09 10/31/20241,910,000 shares $15.47 million +7.3%6.3%39.2 $8.10 10/15/20241,780,000 shares $12.64 million +11.3%5.9%40.2 $7.10 9/30/20241,600,000 shares $10.70 million +6.0%5.3%40.2 $6.69 9/15/20241,510,000 shares $12.53 million +1.3%5.0%42.7 $8.30 8/31/20241,490,000 shares $15.65 million +2.1%4.9%39.3 $10.50 8/15/20241,460,000 shares $14.45 million +1.4%4.8%33.1 $9.90 7/31/20241,440,000 shares $17.86 million -1.4%4.7%30.6 $12.40 7/15/20241,460,000 shares $17.02 million +8.2%4.8%28.9 $11.66 6/30/20241,350,000 shares $15.74 million +2.3%4.4%22.4 $11.66 6/15/20241,320,000 shares $15.83 million +12.8%4.3%18 $11.99 5/31/20241,170,000 shares $16.49 million -12.7%3.8%12.6 $14.09 5/15/20241,340,000 shares $17.07 million -9.5%4.4%14.5 $12.74 4/30/20241,480,000 shares $16.22 million +2.1%5.1%12.3 $10.96 4/15/20241,450,000 shares $16.99 million +10.7%5.0%11.4 $11.72 3/31/20241,310,000 shares $13.96 million No Change4.5%10.6 $10.66 3/15/20241,310,000 shares $14.28 million +2.3%4.5%9.4 $10.90 2/29/20241,280,000 shares $11.37 million +4.1%4.4%11 $8.88 2/15/20241,230,000 shares $9.84 million -3.9%4.2%10.6 $8.00 1/31/20241,280,000 shares $9.72 million -12.9%4.6%13.9 $7.59 1/15/20241,470,000 shares $8.86 million No Change5.3%15 $6.03 12/31/20231,470,000 shares $8.53 million +0.7%5.3%15.6 $5.80 12/15/20231,460,000 shares $8.16 million -4.0%5.2%16.8 $5.59 11/30/20231,520,000 shares $9.48 million +7.0%5.5%18.6 $6.24 11/15/20231,420,000 shares $11.18 million +4.4%5.1%17.9 $7.87 10/31/20231,360,000 shares $9.94 million +19.3%5.1%16.5 $7.31 10/15/20231,140,000 shares $9.21 million -24.5%4.3%13.7 $8.08 9/30/20231,510,000 shares $15.18 million +2.0%5.7%18.9 $10.05 9/15/20231,480,000 shares $15.54 million +5.7%5.6%21.2 $10.50The MAGA 7 Stocks: Huge Upside in 2025 (Ad)The Trump economy is back in full force, and it’s creating huge opportunities for investors. With Trump pushing for lower taxes, fewer regulations, tariffs on foreign competitors, and domestic manufacturing dominance, some stocks are set to skyrocket in value—while others will be left behind. That’s why we put together this free report revealing the 7 MAGA stocks poised to thrive in 2025.🔻 Download the full report now and get the inside track on these 7 powerhouse stocks. 8/31/20231,400,000 shares $14.88 million +7.7%5.3%20.2 $10.63 8/15/20231,300,000 shares $14.04 million -5.8%4.9%17.5 $10.80 7/31/20231,380,000 shares $18.15 million +7.0%5.3%18.8 $13.15 7/15/20231,290,000 shares $16.77 million -5.2%5.0%22.1 $13.00 6/30/20231,360,000 shares $16.14 million +12.4%5.3%21.8 $11.87 6/15/20231,210,000 shares $14.58 million -3.2%4.7%15.8 $12.05 5/31/20231,250,000 shares $14 million -2.3%4.8%16.8 $11.20 5/15/20231,280,000 shares $13.95 million +5.8%5.0%18.6 $10.90 4/30/20231,210,000 shares $10.16 million -4.0%4.7%18.3 $8.40 4/15/20231,260,000 shares $10.16 million No Change4.9%15.8 $8.06 3/31/20231,260,000 shares $10.07 million +22.3%4.9%18.5 $7.99 3/15/20231,030,000 shares $8.63 million +1.0%4.0%18.7 $8.38 2/28/20231,020,000 shares $9.77 million No Change3.9%20.6 $9.58 2/15/20231,020,000 shares $9.87 million -55.5%3.9%19.3 $9.68 1/31/20232,290,000 shares $20.36 million +0.4%9.0%40.2 $8.89 1/15/20232,280,000 shares $21.89 million No Change8.9%56.2 $9.60 12/30/20222,280,000 shares $22.16 million -1.3%8.9%56.6 $9.72 12/15/20222,310,000 shares $22.64 million -5.3%9.0%43.8 $9.80 11/30/20222,440,000 shares $26.69 million -1.6%9.5%49.1 $10.94 11/15/20222,480,000 shares $29.12 million -4.3%9.7%50.2 $11.74 10/31/20222,590,000 shares $26.37 million +1.2%10.5%58.9 $10.18 10/15/20222,560,000 shares $30.05 million -13.2%10.4%61.1 $11.74 9/30/20222,950,000 shares $34.28 million -3.3%11.9%72.7 $11.62 9/15/20223,050,000 shares $38.25 million +4.5%12.3%66.4 $12.54 8/31/20222,920,000 shares $45.41 million -1.4%11.8%54.7 $15.55 8/15/20222,960,000 shares $39.49 million No Change12.0%44.4 $13.34 7/31/20222,960,000 shares $33.03 million -0.3%11.7%33.6 $11.16 7/15/20222,970,000 shares $33.80 million -23.9%11.8%31.3 $11.38 6/30/20223,900,000 shares $38.92 million -1.0%15.4%39 $9.98 6/15/20223,940,000 shares $38.42 million +7.4%15.6%41.5 $9.75 5/31/20223,670,000 shares $36.77 million +8.6%14.5%41 $10.02 5/15/20223,380,000 shares $33.02 million -2.0%13.0%39.8 $9.77 4/30/20223,450,000 shares $50.23 million -3.6%13.2%44.7 $14.56 4/15/20223,580,000 shares $69.52 million +0.9%13.7%42 $19.42 3/31/20223,550,000 shares $64.93 million +0.9%N/A39.2 $18.29 3/15/20223,520,000 shares $54.81 million +2.6%13.5%30.3 $15.57 2/28/20223,430,000 shares $56.60 million +7.5%13.2%22.6 $16.50 2/15/20223,190,000 shares $59.17 million +22.2%12.2%20.1 $18.55 1/31/20222,610,000 shares $44.32 million +34.5%9.9%15.7 $16.98 1/15/20221,940,000 shares $37.27 million +16.2%N/A10.1 $19.21 12/31/20211,670,000 shares $38.96 million +24.6%6.5%9.5 $23.33 12/15/20211,340,000 shares $31.97 million +28.9%5.2%8.2 $23.86 11/30/20211,040,000 shares $27.53 million +7.9%4.0%8.7 $26.47 11/15/2021963,900 shares $21.30 million +5.0%4.0%11 $22.10 10/29/2021917,900 shares $23.23 million -0.5%3.7%11.5 $25.31 10/15/2021922,500 shares $15.68 million -0.9%3.7%19.2 $17.00 9/30/2021930,900 shares $20.54 million -17.6%3.8%18.7 $22.06 9/15/20211,130,000 shares $26.37 million +3.7%4.6%11.3 $23.34 8/31/20211,090,000 shares $23.84 million +5.8%4.4%9.6 $21.87 8/13/20211,030,000 shares $21.63 million No Change4.2%7.5 $21.00Is President Trump Lying To You With This? (Ad)President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.Protect your IRA—Trump’s warning was real GHRS Short Interest - Frequently Asked Questions What is GH Research's current short interest? Short interest is the volume of GH Research shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 2,820,000 shares of GHRS short. 6.97% of GH Research's shares are currently sold short. Learn More on GH Research's current short interest. What is a good short interest ratio for GH Research? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GHRS shares currently have a short interest ratio of 11.0. Learn More on GH Research's short interest ratio. Which institutional investors are shorting GH Research? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GH Research: PEAK6 LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for GH Research? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.97% of GH Research's floating shares are currently sold short. Is GH Research's short interest increasing or decreasing? GH Research saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 2,820,000 shares, a drop of 2.1% from the previous total of 2,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GH Research's float size? GH Research currently has issued a total of 52,028,000 shares. Some of GH Research's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GH Research currently has a public float of 40,440,000 shares. How does GH Research's short interest compare to its competitors? 6.97% of GH Research's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to GH Research: NewAmsterdam Pharma (8.68%), Kymera Therapeutics, Inc. (11.03%), Biohaven Ltd. (7.65%), Denali Therapeutics Inc. (9.34%), ImmunityBio, Inc. (7.79%), Harmony Biosciences Holdings, Inc. (7.46%), Twist Bioscience Co. (16.62%), Belite Bio, Inc (0.23%), Kiniksa Pharmaceuticals, Ltd. (4.56%), Arrowhead Pharmaceuticals, Inc. (9.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short GH Research stock? Short selling GHRS is an investing strategy that aims to generate trading profit from GH Research as its price is falling. GHRS shares are trading down $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GH Research? A short squeeze for GH Research occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GHRS, which in turn drives the price of the stock up even further. How often is GH Research's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GHRS, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies NAMS Short Squeeze KYMR Short Squeeze BHVN Short Squeeze DNLI Short Squeeze IBRX Short Squeeze HRMY Short Squeeze TWST Short Squeeze BLTE Short Squeeze KNSA Short Squeeze ARWR Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GHRS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GH Research PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share GH Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.